bioAffinity Technologies, Inc. (BIAF) Capital expenditures 2022–2025
bioAffinity Technologies, Inc. (BIAF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$60,568FY2025 · since FY2022: $219,987 → $60,568
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $60,568 | -23.4% |
| FY2024 | $79,083 | +245.3% |
| FY2023 | $22,902 | -89.6% |
| FY2022 | $219,987 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice